Literature DB >> 19937058

A family with X-linked benign familial hematuria.

Kazunari Kaneko1, Sachiyo Tanaka, Masafumi Hasui, Kandai Nozu, Rafal Przybyslaw Krol, Kazumoto Iijima, Keisuke Sugimoto, Tsukasa Takemura.   

Abstract

Gene mutations in COL4A5 located on Xq22 are believed to cause X-linked Alport syndrome, whereas mutations in COL4A3 and COL4A4 located on chromosome 2 are associated with autosomal inherited Alport syndrome or benign familial hematuria. A family with benign familial hematuria caused by COL4A5 mutation, implying X-linked transmission, is reported here for the first time. This result suggests that COL4A5 should be added to the list of causative genes for benign familial hematuria, although the mechanism(s) by which the same mutation leads to the distinct phenotypes, i.e. X-linked Alport syndrome or benign familial hematuria, remains unknown.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19937058     DOI: 10.1007/s00467-009-1370-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Somatic mosaicism associated with a mild Alport syndrome phenotype.

Authors:  K E Plant; E Boye; P M Green; D Vetrie; F A Flinter
Journal:  J Med Genet       Date:  2000-03       Impact factor: 6.318

Review 2.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen.

Authors:  Billy G Hudson; Karl Tryggvason; Munirathinam Sundaramoorthy; Eric G Neilson
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

3.  Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.

Authors:  H H Lemmink; W N Nillesen; T Mochizuki; C H Schröder; H G Brunner; B A van Oost; L A Monnens; H J Smeets
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

4.  Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria.

Authors:  Cèlia Badenas; Manuel Praga; Bárbara Tazón; Laurence Heidet; Christelle Arrondel; Anna Armengol; Amado Andrés; Enrique Morales; Juan Antonio Camacho; Xose Lens; Sonia Dávila; Montse Milà; Corinne Antignac; Alejandro Darnell; Roser Torra
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

5.  Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome.

Authors:  B Knebelmann; C Breillat; L Forestier; C Arrondel; D Jacassier; I Giatras; L Drouot; G Deschênes; J P Grünfeld; M Broyer; M C Gubler; C Antignac
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

6.  Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling.

Authors:  Oliver Gross; Kai-Olaf Netzer; Romy Lambrecht; Stefan Seibold; Manfred Weber
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

7.  Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis.

Authors:  Alkis Pierides; Konstantinos Voskarides; Yiannis Athanasiou; Kyriacos Ioannou; Loukas Damianou; Maria Arsali; Michalis Zavros; Michael Pierides; Vasilios Vargemezis; Charalambos Patsias; Ioanna Zouvani; Avraam Elia; Kyriacos Kyriacou; Constantinos Deltas
Journal:  Nephrol Dial Transplant       Date:  2009-04-08       Impact factor: 5.992

8.  Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.

Authors:  M Slajpah; B Gorinsek; G Berginc; A Vizjak; D Ferluga; A Hvala; A Meglic; I Jaksa; P Furlan; A Gregoric; S Kaplan-Pavlovcic; M Ravnik-Glavac; D Glavac
Journal:  Kidney Int       Date:  2007-03-28       Impact factor: 10.612

9.  Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.

Authors:  Rafal Przybyslaw Krol; Kandai Nozu; Koichi Nakanishi; Kazumoto Iijima; Yasuhiro Takeshima; Xue Jun Fu; Yoshimi Nozu; Hiroshi Kaito; Kyoko Kanda; Masafumi Matsuo; Norishige Yoshikawa
Journal:  Nephrol Dial Transplant       Date:  2008-03-10       Impact factor: 5.992

10.  Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients.

Authors:  N Patey-Mariaud de Serre; M Garfa; B Bessiéres; L H Noël; B Knebelmann
Journal:  Kidney Int       Date:  2007-06-06       Impact factor: 10.612

View more
  9 in total

1.  Somatic mosaicism and variant frequency detected by next-generation sequencing in X-linked Alport syndrome.

Authors:  Xue Jun Fu; Kandai Nozu; Hiroshi Kaito; Takeshi Ninchoji; Naoya Morisada; Koichi Nakanishi; Norishige Yoshikawa; Hiromi Ohtsubo; Natsuki Matsunoshita; Naohiro Kamiyoshi; Chieko Matsumura; Nobuaki Takagi; Kohei Maekawa; Mariko Taniguchi-Ikeda; Kazumoto Iijima
Journal:  Eur J Hum Genet       Date:  2015-05-27       Impact factor: 4.246

2.  Identification of a novel COL4A5 mutation in a Chinese family with X-linked Alport syndrome using exome sequencing.

Authors:  Yi Guo; Jinzhong Yuan; Hui Liang; Jingjing Xiao; Hongbo Xu; Lamei Yuan; Kai Gao; Bin Wu; Yongchang Tang; Xiaorong Li; Hao Deng
Journal:  Mol Biol Rep       Date:  2014-02-13       Impact factor: 2.316

Review 3.  X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure.

Authors:  A Pierides; K Voskarides; M Kkolou; M Hadjigavriel; C Deltas
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

Review 4.  The role of molecular genetics in diagnosing familial hematuria(s).

Authors:  Constantinos Deltas; Alkis Pierides; Konstantinos Voskarides
Journal:  Pediatr Nephrol       Date:  2011-06-19       Impact factor: 3.714

5.  Identification of a novel collagen type IV alpha-4 (COL4A4) mutation in a Chinese family with autosomal dominant Alport syndrome using exome sequencing.

Authors:  Sheng Deng; Hongbo Xu; Jinzhong Yuan; Jingjing Xiao; Lamei Yuan; Xiong Deng; Liping Guan; Anding Zhu; Pengfei Rong; Jianguo Zhang; Hao Deng
Journal:  Indian J Med Res       Date:  2016-08       Impact factor: 2.375

6.  Trimerization and Genotype-Phenotype Correlation of COL4A5 Mutants in Alport Syndrome.

Authors:  Misato Kamura; Tomohiko Yamamura; Kohei Omachi; Mary Ann Suico; Kandai Nozu; Shota Kaseda; Jun Kuwazuru; Tsuyoshi Shuto; Kazumoto Iijima; Hirofumi Kai
Journal:  Kidney Int Rep       Date:  2020-01-30

7.  Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome.

Authors:  Joel T Gibson; Mary Huang; Marina Shenelli Croos Dabrera; Krushnam Shukla; Hansjörg Rothe; Pascale Hilbert; Constantinos Deltas; Helen Storey; Beata S Lipska-Ziętkiewicz; Melanie M Y Chan; Omid Sadeghi-Alavijeh; Daniel P Gale; Agne Cerkauskaite; Judy Savige
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

8.  Combination of a Novel Genetic Variant in CFB Gene and a Pathogenic Variant in COL4A5 Gene in a Sibling Renal Disease: A Case Report.

Authors:  Feng-Mei Wang; Yan Yang; Xiao-Liang Zhang; Yan-Li Wang; Yan Tu; Bi-Cheng Liu; Bin Wang
Journal:  Front Genet       Date:  2021-07-19       Impact factor: 4.599

Review 9.  Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome.

Authors:  Kandai Nozu; Yutaka Takaoka; Hirofumi Kai; Minoru Takasato; Kensuke Yabuuchi; Tomohiko Yamamura; Tomoko Horinouchi; Nana Sakakibara; Takeshi Ninchoji; China Nagano; Kazumoto Iijima
Journal:  Kidney Res Clin Pract       Date:  2020-12-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.